1. Home
  2. SNOA vs AQMS Comparison

SNOA vs AQMS Comparison

Compare SNOA & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • AQMS
  • Stock Information
  • Founded
  • SNOA 1999
  • AQMS 2014
  • Country
  • SNOA United States
  • AQMS United States
  • Employees
  • SNOA N/A
  • AQMS N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • AQMS Metal Fabrications
  • Sector
  • SNOA Health Care
  • AQMS Industrials
  • Exchange
  • SNOA Nasdaq
  • AQMS Nasdaq
  • Market Cap
  • SNOA 6.4M
  • AQMS 5.5M
  • IPO Year
  • SNOA 2007
  • AQMS 2015
  • Fundamental
  • Price
  • SNOA $3.56
  • AQMS $0.60
  • Analyst Decision
  • SNOA
  • AQMS Strong Buy
  • Analyst Count
  • SNOA 0
  • AQMS 3
  • Target Price
  • SNOA N/A
  • AQMS $21.00
  • AVG Volume (30 Days)
  • SNOA 83.7K
  • AQMS 6.5M
  • Earning Date
  • SNOA 08-07-2025
  • AQMS 08-04-2025
  • Dividend Yield
  • SNOA N/A
  • AQMS N/A
  • EPS Growth
  • SNOA N/A
  • AQMS N/A
  • EPS
  • SNOA N/A
  • AQMS N/A
  • Revenue
  • SNOA $14,288,000.00
  • AQMS N/A
  • Revenue This Year
  • SNOA $23.00
  • AQMS N/A
  • Revenue Next Year
  • SNOA $24.59
  • AQMS $550.00
  • P/E Ratio
  • SNOA N/A
  • AQMS N/A
  • Revenue Growth
  • SNOA 12.20
  • AQMS N/A
  • 52 Week Low
  • SNOA $1.75
  • AQMS $0.47
  • 52 Week High
  • SNOA $9.00
  • AQMS $7.40
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 59.09
  • AQMS 47.08
  • Support Level
  • SNOA $2.97
  • AQMS $0.49
  • Resistance Level
  • SNOA $3.75
  • AQMS $0.62
  • Average True Range (ATR)
  • SNOA 0.27
  • AQMS 0.09
  • MACD
  • SNOA 0.06
  • AQMS 0.03
  • Stochastic Oscillator
  • SNOA 55.83
  • AQMS 25.67

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

Share on Social Networks: